Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue (DESeRT)

This study has been completed.
Tibotec Pharmaceutical Limited
Information provided by:
University of North Carolina, Chapel Hill Identifier:
First received: March 2, 2009
Last updated: May 11, 2011
Last verified: May 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2011
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)